Doctolib strengthens its AI offering through the acquisition of Typeless
25.06.2024 12:46
Doctolib has announced the acquisition of AI speech recognition specialist Typeless. The acquisition is a further step in Doctolib's AI strategy and is intended to accelerate the development of its digital medical assistant, planned for release by the end of 2024.
Typeless was founded in Lausanne in 2022 by a team of experts led by Matthieu Le Cauchois and specializes in developing advanced AI-based speech recognition for the medical field. The technology uses Large Language Models (LLM) to efficiently convert spoken language into structured text, thereby reducing the documentation workload for medical personnel.
Integration of voice-to-text technology into Doctolib's medical assistant
Typeless' voice-to-text technology will be integrated into Doctolib's planned medical assistant. This will allow the conversation between doctor and patient regarding the patient's condition, diagnosis, medication, and treatment plans to be transcribed into a standardized medical report. Doctors and medical assistants will no longer need to take notes during the patient consultation or document the conversation afterward. By combining existing Doctolib features with the new AI-powered speech recognition, practice teams will have more time for their patients.
The acquisition of Typeless marks the next step in the AI strategy.
The acquisition of Typeless is part of Doctolib's strategy to integrate artificial intelligence into further product development – following the acquisition of Aaron.ai and the expansion of its offering to include an AI-based telephone assistant in May 2024. With its expertise in data science, artificial intelligence, and robotics, the Typeless team will now strengthen Doctolib's AI development efforts.
Nikolay Kolev, Managing Director of Doctolib in Germany and member of the global board:
„The integration of Typeless and its team of experts is another step in expanding our AI strategy. Following the recent acquisition of Aaron.ai, we are now strengthening our commitment to supporting healthcare teams with leading technology, easing their daily workload and giving them more time to care for their patients.“
Matthieu Le Cauchois, co-founder and CEO of Typeless:
„The opportunity to join Doctolib is an important step for our team. I am very pleased that our technology will now help an even larger network of doctors and practice teams save time documenting conversations between doctors and patients.“
Further information about the functions of the new medical assistant will be announced as development progresses.